The Foundation for Research and Technology – Hellas (FORTH) was founded in 1983.
It is the premier multidisciplinary research institution in Greece with well-organized facilities, highly qualified personnel and a reputation as a top-level research institution worldwide.
How does nature utilize the common repertoire of folds in proteins to differentiate their specificity, and ultimately their function? This long-standing and fundamental question was addressed in a study conducted at the Institute of Molecular Biology and Biotechnology of the Foundation for Research & Technology-Hellas (FORTH-IMBB). The results of this
IMBB researchers reveal that DNA damage in tissue-infiltrating macrophages triggers an exosome-based metabolic reprogramming leading to chronic inflammation.
Research carried out at the Institute of Molecular Biology and Biotechnology (IMBB) of FORTH, provides evidence that persistent DNA damage triggers an exosome-based, metabolic reprogramming that leads to chronic inflammation and tissue pathology in DNA repair-deficient progeroid syndromes and likely also during aging.
Participation of FORTH/ICE-HT at the 7th Meeting of China-CEEC Higher Education Institutions Consortium
The 7th meeting of China-CEEC Higher Education Institutions Consortium entitled «Promoting the Sustainable Development of Education Cooperation between China and Central & Eastern European Countries» took place on December 2, 2021. Greece participated through the presentation by Dr. Maria Klapa, Principal Researcher of the Institute of Chemical Engineering Sciences of
FORTH/ICE-HT (www.iceht.forth.gr) has created the “Stratis V. Sotirchos Lectureship” to honor the memory of one of its most distinguished Researchers, Professor Stratis V. Sotirchos. This Award is supported by the “Stratis V. Sotirchos Trust Fund”, which has been created from donations by friends and colleagues.
The Foundation for Research and Technology-Hellas (FORTH) and its Institutes have been made available to the State and Public Health Authorities, in order to contribute to the common effort to address the pandemic of COVID-19, with their top-level infrastructure and expertise.